Large protein machines in the body carry out many of the cell's most essential tasks, from energy production to the ...
Bristol-Myers Squibb has become the latest drugmaker in the US to file a legal challenge to a block on a drug rebate model opposed by a Health and Human Services (HHS) department. Specifically, BMS is ...
A new computational method allows modern atomic models to learn from experimental thermodynamic data, according to a ...
Bristol-Myers Squibb has decided to gamble on the FDA approving Karuna Therapeutics’ schizophrenia drug candidate KarXT next year, agreeing to buy the company for approximately $14 billion. The ...
Each AI model was fed detailed scenario prompts spanning border conflicts, resource shortages, and existential threats to state survival. They were provided with an "escalation ladder," ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results